Anavex Life Sciences (AVXL) Tops Q1 EPS by 2c

Anavex Life Sciences (NASDAQ: AVXL) reported Q1 EPS of ($0.17), $0.02 better than the analyst estimate of ($0.19).

For earnings history and earnings-related data on Anavex Life Sciences (AVXL) click here.

You May Also Be Interested In

• Anavex Life Sciences Mails Letter to Stockholders Reinforcing Relevant Experience of All Six Director Nominees
• BitFuFu Inc. (FUFU) Misses Q2 EPS by 13c
• The LGL Group (LGL) Misses Q2 EPS by 8c